1. Home
  2. XOMA vs NREF Comparison

XOMA vs NREF Comparison

Compare XOMA & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • NREF
  • Stock Information
  • Founded
  • XOMA 1981
  • NREF 2019
  • Country
  • XOMA United States
  • NREF United States
  • Employees
  • XOMA N/A
  • NREF N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • NREF Real Estate Investment Trusts
  • Sector
  • XOMA Health Care
  • NREF Real Estate
  • Exchange
  • XOMA Nasdaq
  • NREF Nasdaq
  • Market Cap
  • XOMA 250.1M
  • NREF 275.2M
  • IPO Year
  • XOMA N/A
  • NREF 2020
  • Fundamental
  • Price
  • XOMA $19.30
  • NREF $14.90
  • Analyst Decision
  • XOMA Strong Buy
  • NREF Hold
  • Analyst Count
  • XOMA 2
  • NREF 4
  • Target Price
  • XOMA $72.00
  • NREF $15.00
  • AVG Volume (30 Days)
  • XOMA 30.1K
  • NREF 47.2K
  • Earning Date
  • XOMA 03-17-2025
  • NREF 05-01-2025
  • Dividend Yield
  • XOMA N/A
  • NREF 13.43%
  • EPS Growth
  • XOMA N/A
  • NREF 69.45
  • EPS
  • XOMA N/A
  • NREF 1.02
  • Revenue
  • XOMA $28,487,000.00
  • NREF $73,091,000.00
  • Revenue This Year
  • XOMA $29.60
  • NREF $27.07
  • Revenue Next Year
  • XOMA $34.18
  • NREF $3.57
  • P/E Ratio
  • XOMA N/A
  • NREF $14.65
  • Revenue Growth
  • XOMA 498.72
  • NREF 73.65
  • 52 Week Low
  • XOMA $19.12
  • NREF $12.63
  • 52 Week High
  • XOMA $35.00
  • NREF $18.09
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 27.79
  • NREF 34.40
  • Support Level
  • XOMA $20.45
  • NREF $14.50
  • Resistance Level
  • XOMA $21.45
  • NREF $16.80
  • Average True Range (ATR)
  • XOMA 0.80
  • NREF 0.61
  • MACD
  • XOMA 0.05
  • NREF -0.11
  • Stochastic Oscillator
  • XOMA 6.49
  • NREF 17.22

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

About NREF NexPoint Real Estate Finance Inc.

NexPoint Real Estate Finance Inc is a real estate investment trust. It provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.

Share on Social Networks: